Methionine PET/CT Studies In Patients With Cancer

PHASE2Active, not recruitingINTERVENTIONAL
Enrollment

503

Participants

Timeline

Start Date

July 20, 2009

Primary Completion Date

July 27, 2027

Study Completion Date

July 27, 2027

Conditions
Brain Tumors and/or Solid Tumors IncludingBrain Stem GliomaHigh Grade CNS TumorsEpendymomaMedulloblastomaCraniopharyngiomaLow Grade CNS TumorsHodgkin LymphomaNon Hodgkin LymphomaEwing SarcomaOsteosarcomaRhabdomyosarcomaNeuroblastomaOther
Interventions
DRUG

Methionine

Intravenous injection

Trial Locations (1)

38119

St. Jude Children's Research Hospital, Memphis

All Listed Sponsors
lead

St. Jude Children's Research Hospital

OTHER

NCT00840047 - Methionine PET/CT Studies In Patients With Cancer | Biotech Hunter | Biotech Hunter